Navigation Links
Commercial Insurers' Reimbursement Rate to New York's Community Health Centers Jeopardizes Care
Date:10/1/2007

e delivery at the more than 50 community health care centers with over 425 sites throughout the state. From clinical excellence to health information technology, from emergency preparedness to eliminating health care disparities, CHCANYS' goal is to provide community health centers with the resources needed to provide high quality, community- based primary care to anyone in need regardless of their ability to pay. For more information about CHCANYS, contact Chief Executive Officer Elizabeth Swain at 212/710-3802 or go to http://www.chcanys.org.

About the RCHN Community Health Foundation

The RCHN Community Health Foundation (RCHN CHF) is a New York-based not- for-profit operating foundation dedicated to supporting and benefiting community health centers (CHCs) in New York state and nationally. The Foundation develops and supports programmatic and business initiatives related to community health center access, pharmacy and health information technology through strategic investment, research, outreach, education, and coalition building and advocacy. For more information about RCHN CHF, contact Chief Operating Officer Feygele Jacobs at (212) 246-1122, ext. 712, or visit http://www.rchnfoundation.org

For more information:

CHCANYS: Libby Post, 518/438-2826

Cell: 518/857-6788

E-mail: lpost@commservices.net

RCHN: Victoria Grantham, 917/328-3287

Email: vgrantham@rosecomm.com


'/>"/>
SOURCE CHCANYS; RCHN CHF
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. TV drug commercials prompt prescriptions
2. Commercialization of Biotech Discoveries, An Encouragement For Researchers
3. A Move To Help Commercial Sex Workers Quit Their Business
4. Commercial grape juices and vinegars found rich in antioxidants
5. Widespread Commercialisation Of Human Organ Donation In China
6. Commercialization of drugs by fast tracking is a cause of concern
7. Formula milk suffering due to commercial interests
8. Spine Gourd Variety Helpful For Diabetics Is Ready For Commercial Cultivation
9. Updated Sleep Apnea Screening Recommended for Commercial Drivers
10. Magnets in Commercial Products may Cause a Fatal Attraction
11. The Psyche Behind Drug Commercials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...has got the approval of US Food and Drug Administr...ation (ANDA) for Meloxicam tablets used in the tre... // The approval is for Meloxicam tablets of stre... the company informed the Bombay Stock Exchange. "...
... injection users in US and South Africa practice u...g to a new study. // "Forty percent of the HIV-pos...risk male partners, and more than half of the time... said lead author Dr. Mary H. Latka. The study is ...
...children are to be weighed, measured and interview...ned to tackle //the growing menace of childhood ob...about 25 percent of the children aged between 7 an... This problem is increasing the incidence of heart...
...ation confirmed the 42nd human bird flu death in I... the two worst-hit by the virus,//a senior officia...day. "The result was positive, we received from t... today," Hariadi Wibisono, the director at the min...
Other Medicine News:
(Date:8/26/2008)...IANAPOLIS, Aug. 26 /- Semafore Pharma...national Congress on Targeted Therapies,in Cancer ...ovel,multi-targeted kinase inhibitors that demonst...l studies., A novel and proprietary molecular sca...ing allowing for the design of pan-PI3 kinase inhi...
(Date:8/26/2008)...T WORTH, Texas, Aug. 26 /- Healthpoin... trial to evaluate the effectiveness of a,widely p...aneous wounds and,resulting scars. The pilot study... reduced incidence of hypertrophic scars and benef...se SANTYL(R) Ointment.(1,2), "Given the findings ...
(Date:8/26/2008)...LO PARK, Calif., Aug. 26 /-... the positive one-year follow-up data,from the CUS...e of the,peer-reviewed journal, EuroIntervention. ...tella, M.D., of University Medical Center Utrecht,...II Investigators from 13 clinical,sites across Eur...
(Date:8/26/2008)...TTLE, Aug. 26 /- Omeros Corporation t... a Phase 1/Phase 2 trial investigating,OMS103HP in...onstruction,surgery. OMS103HP is an investigationa...ation solution and is designed to improve postoper...ve pain and allow patients an,earlier return to wo...
Breaking Medicine Technology:Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2New technology enhances therapeutic potential of cord blood stem cells 3551 1New technology enhances therapeutic potential of cord blood stem cells 3551 2DURECT Corporation to Participate in Upcoming Healthcare Conferences 5853 1Walking Golf Course Affects Swing Performance 21249 1Walking Golf Course Affects Swing Performance 21249 2US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 1US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 2US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 3US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 4US FDA Grants Pediatric Exclusivity for UCBs Keppra 28R 29 5852 5
...he Intramuscular Formulation,of Peramivir Supports...za, BIRMINGHAM, Ala., June 18, 2007 /PRNewswire-Fi...ed results from two Phase I,clinical studies of an...the Options for the Control of Influenza Conferenc...ional influenza,conference is held only once every...
...PRNewswire-FirstCall/ --,Genaera Corporation today...quemine (MSI-1436), its novel anti-obesity compoun...67th Scientific,Sessions, June 22 to 25 in Chicago...ine is a Multiple,Pathway Inhibitor that Causes Di...roves Plasma Insulin and Leptin Levels." , The pos...
Other Medicine Technology:BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 2BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 3BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 4BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 5BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference 6Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 2Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 3Genaera to Present Preclinical Data on Trodusquemine for the,Treatment of Obesity at the American Diabetes Association 67th,Scientific Sessions 4
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
Medicine Products: